Evan Feldman, MD
Colon & Rectal Surgery · Atlanta, GANPI 1750530630
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,776 of the $6,624 with a category attached, or 72.1%. 35 manufacturers reported payments, led by Intuitive Surgical at 27.7% of the total. Reporting peaked in 2019 at $2,270 and has fallen 81.4% since, to $422 in 2025.
Across 132 payments — averaging $50.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Medtronic$962
- Musculoskeletal Transplant Foundation Inc.$935
- Stryker$630
- Davol Inc.$290
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$274
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1,84828%
- Food & beverage$4,77672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $1,836 |
| Medtronic | 30 | $962 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $935 |
| Stryker | 2 | $630 |
| Davol Inc. | 4 | $290 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $274 |
| La Jolla Pharmaceutical Company | 6 | $157 |
| Applied Medical Resources Corporation | 1 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Ferring Pharmaceuticals Inc. | 8 | $130 |
| Conmed Corporation | 1 | $111 |
| Axonics, Inc. | 4 | $96 |
| Covidien LP | 5 | $86 |
| Baxter Healthcare | 3 | $70 |
| THD America, Inc. | 2 | $66 |
| Johnson & Johnson | 3 | $62 |
| Lexington Medical, Inc. | 1 | $60 |
| Braintree Laboratories, Inc. | 3 | $55 |
| Smith+Nephew | 1 | $41 |
| Shire North American Group Inc | 2 | $41 |
| Boston Scientific | 3 | $39 |
| Merck | 3 | $39 |
| Heron Therapeutics, Inc. | 2 | $37 |
| Mimedx Group, Inc. | 2 | $36 |
| KCI USA, Inc. | 1 | $36 |
| Micro-tech Endoscopy USA, Inc. | 1 | $31 |
| Convatec Inc. | 2 | $30 |
| Integra Lifesciences Corporation | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Innovation Technologies Inc | 1 | $25 |
| Trevena, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $20 |
| AbbVie | 1 | $18 |
| Prescient Surgical | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,629
- 1588 HD 3 CHIP CAMERA$567
- GI Genius$289
- Surgiphor$192
- AIRSEAL$111
How this compares
$6,624 in reported general payments places this provider in the 60th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 12 | $531,216 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 26 | $4,474 |
| Ondansetron OdtOndansetron | 82 | $429 |
| Lidocaine | 12 | $349 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $299 |
| LoperamideLoperamide Hcl | 13 | $297 |
| Oxycodone Hcl | 59 | $271 |
| Neomycin Sulfate | 51 | $259 |
| Metronidazole | 58 | $129 |
| Ondansetron Hcl | 34 | $120 |
| Ciprofloxacin Hcl | 11 | $90 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $153 | $531,21612 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $130 | $4,47426 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 66 colon & rectal surgery providers in Georgia.
Other colon & rectal surgery in Atlanta
- Patrick SullivanAtlanta$41K
- Sander BinderowAtlanta$20K
- Daniel Sarmiento GarzonAtlanta$14K
- Joseph MarenoAtlanta$13K
- Jessica LamAtlanta$8K
- Cici ZhangAtlanta$5K
- Ellen CaparosaAtlanta$5K
- Monica HumAtlanta$5K
- Gie YuAtlanta$3K
- Stephanie PappasAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.